Please find enclosed Transcript for the Earnings call held on Tuesday, November 03, 2026 for the Q2 & H1 FY 27.

November 07, 2026 The General Manager, Listing Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001 Scrip Code: 540078 Dear Sir/Madam Sub: Transcript of Conference Call with Investors and Analysts held on November 03, 2026 In Continuation to our intimation dated October 27, 2026 please find enclosed a transcript of the Earnings Call held on Tuesday, November 03, 2026 for the second quarter ended on September 30, 2026. The transcript is also available on the Company’s website at https://www.mitsuchem.com/investors/financial-results/ You are requested to take the same on your records. Thanking you. Yours truly, FOR MITSU CHEM PLAST LIMITED Manish Mavji Dedhia Managing Director & CFO (DIN:01552841) Encl: as above “Mitsu Chem Plast Limited Q2 & H1 FY '27 Earnings Conference Call” November 03, 2026 MANAGEMENT: MR. MANISH DEDHIA – MANAGING DIRECTOR & CHIEF FINANCIAL OFFICER, MITSU CHEM PLAST LIMITED MS. KASHMIRA DEDHIA – VICE PRESIDENT (FINANCE & ACCOUNTS), MITSU CHEM PLAST LIMITED Page 1 of 15 Mitsu Chem Plast Limited November 03, 2026 Moderator: Ladies and gentlemen, good day and welcome to Mitsu Chem Plast Limited Q2 and H1 FY '27 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during this conference call, please signal an operator by pressing “*” then “0” on your touch- tone phone. Please note that this conference is being recorded. I now hand the conference over to Mr. Suyash Samant from Stellar IR Advisors. Thank you and over to you, Mr. Samant. Suyash Samant: Thank you. Good morning, everyone and thank you for joining us today. I have with us today the senior management team of Mitsu Chem Plast Limited, Mr. Manish Dedhia - Managing Director and CFO along with Ms. Kashmira Dedhia - VP Finance and Accounts, who will represent Mitsu Chem Plast Limited on the call. The management will be sharing operating and financial highlights for the quarter ended September 30, 2026 followed by a question-and-answer session. Please note this call may contain some of the forward-looking statements which are completely based upon the company's beliefs, opinions and expectations as of today. These statements are not a guarantee of the company's future performance and involve unforeseen risk and uncertainties. The company also undertakes no obligation to update any forward-looking statement to reflect developments that occur after a statement is made. I now hand over the conference to Mr. Manish Dedhia. Thank you and over to you, sir. Manish Dedhia: Thank you, Suyash. Good morning to everyone. It is a pleasure to welcome all investors, analysts and participants to the Mitsu Chem Plast Limited Q2 and H1 FY '27 Earnings Conference Call. We sincerely appreciate your continued interest and support. I will take you through our business performance, the progress across our key segments and the opportunities we are pursuing to drive our next phase of growth. We have built a strong manufacturing platform over more than three decades with expertise across blow molding, injection molding and customized plastic products. Our manufacturing footprint comprises four facilities with 58 blow molding machines and 22 injection molding machines, with total manufacturing capacity having reached over 36,000 plus metric tons per annum. Our portfolio spans industrial containers ranging from approximately 100 ml to 250 liters, serving diverse industries including chemicals, pharmaceuticals, lubricants, edible oils, pesticides, dyes and specialty chemicals, fragrance, food and agrochemicals. This diversified end-market exposure provides multiple avenues for growth and reduces dependence Page 2 of 15 Mitsu Chem Plast Limited November 03, 2026 on any single industry. We have a diversified customer base of 700 plus customers supported by a long-standing relationship with several customers. We also have a strong export presence across 18 countries, providing a broad geographic footprint and access to international market. These capabilities position us well to capture emerging opportunities, particularly from the growing China Plus One sourcing trend and increasing demand for reliable Indian manufacturing partners. Coming to our product verticals: Q2 FY '27 or H1 FY '27 as per results reflected the scale of our core industrial packaging business along with growth across our emerging segment. Industrial packaging revenue stood at approximately 81.88%, hospital furniture parts revenue approximately 16.27%, infrastructure furniture and other recorded revenue of approximately 1.86% of total revenue for Q1 FY '26-27. Industrial packaging remains our core business while the other verticals are helping us diversify our revenue mix. Our priorities include improving manpower, machinery and material efficiency, increasing the share of higher margin products, developing new products and molds, particularly for healthcare and expanding exports through new customer engagement and international exhibitions. Furnastra, launched in 2025, provides a dedicated brand for our hospital furniture parts business, covering hospital bed components, side railings, bed boards, mattresses, platforms and other healthcare products. We continue to expand the portfolio through new molds and differentiate solutions, including our patented product with an inbuilt CPR profile. With healthcare infrastructure expanding, we see opportunities to grow this business through new product customer additions and exports. Another key initiative is our entry into the Intermediate Bulk Container or IBCs, serving industries such as chemicals, pharmaceuticals, food and beverages, and agrochemicals. Our fully automated Khalapur facility for 1,000-liter IBC container is expected to be operational by Q3 FY 2027. The vertical offers attractive potential with capital turnover of approximately 15 times, compared with around 8-10 times for other products. Packaging will remain our primary growth driver, complemented by IBCs and other higher value-added products. Our ambition is to achieve Rs. 1,000 crores in annual revenue by FY '28. We remain focused on capacity expansion, higher value product categories, operational efficiency, and expanding our domestic and international presence. I would like to thank our employees, customers, business partners, and shareholders for their continued trust and support. With this, I conclude my opening remarks and request Ms. Kashmira Dedhia to take you through the financial performance for the quarter ended September 30, 2026. Thank you. Page 3 of 15 Mitsu Chem Plast Limited November 03, 2026 Kashmira Dedhia: Good morning, everyone. Thank you, Manish sir. I will walk you through our financial performance for quarter 2 and H1 FY '27. Mitsu Chem Plast Limited reported strong improvement in profitability supported by better operating efficiency and improved product mix. For Q2 FY '27, revenue from operations stood at Rs. 9,580.87 lakhs compared to Rs. 9,242.05 lakhs in Q2 FY '26, representing a year-on-year change of 3.67%. EBITDA stood at Rs. 1,188.55 lakhs up by Rs. 101.97% year-on-year with a margin of 12.41%. While profit after tax was Rs. 610.47 lakhs up to 224.12% year-on-year with a PAT margin of 6.37%. For H1 FY '27, revenue from operations stood at Rs. 19,095.40 lakhs representing a year-on-year change of 7.46%. EBITDA for the first half was Rs. 2,738.03 lakhs up by Rs. 151.40% year-on-year with a margin of 14.34% while profit after tax stood at Rs. 1,484.30 lakhs up 364.56% year-on-year with a PAT margin of 7.77%. Coming to our balance sheet and return ratio: Our total borrowing stood at around Rs. 9,648.44 lakhs with cash and bank balance of Rs. 6.07 lakhs as of September 2026. Our debt-to-equity ratio stood at 0.76x in H1 FY '27. Our financial portfolio remained focused on improving profitability, strengthening cas [Showing first 8,000 characters — download PDF for full document]